NO981136L - Farmasöytiske kombinasjonspreparater inneholdende erytropoietin og jernpreparater - Google Patents

Farmasöytiske kombinasjonspreparater inneholdende erytropoietin og jernpreparater

Info

Publication number
NO981136L
NO981136L NO981136A NO981136A NO981136L NO 981136 L NO981136 L NO 981136L NO 981136 A NO981136 A NO 981136A NO 981136 A NO981136 A NO 981136A NO 981136 L NO981136 L NO 981136L
Authority
NO
Norway
Prior art keywords
preparations
combined pharmaceutical
iron
containing erythropoietin
pharmaceutical preparations
Prior art date
Application number
NO981136A
Other languages
English (en)
Other versions
NO329908B1 (no
NO981136D0 (no
Inventor
Paul Lehmann
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of NO981136L publication Critical patent/NO981136L/no
Publication of NO981136D0 publication Critical patent/NO981136D0/no
Publication of NO329908B1 publication Critical patent/NO329908B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO19981136A 1995-09-14 1998-03-13 Anvendelse av erytropoietin og et jernpreparat for fremstilling av et farmasoytisk kombinasjonspreparat for behandling av hemodialysepasienter, eller for behandling av anemier NO329908B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19535571A DE19535571A1 (de) 1995-09-14 1995-09-14 Pharmazeutische Kombinationspräparate und deren Verwendung zur Behandlung von Hämodialysepatienten
PCT/EP1996/003997 WO1997009996A1 (de) 1995-09-14 1996-09-12 Pharmazeutische kombinationspräparate enthaltend erythropoietin und eisenpräparate

Publications (3)

Publication Number Publication Date
NO981136L true NO981136L (no) 1998-03-13
NO981136D0 NO981136D0 (no) 1998-03-13
NO329908B1 NO329908B1 (no) 2011-01-24

Family

ID=7773098

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19981136A NO329908B1 (no) 1995-09-14 1998-03-13 Anvendelse av erytropoietin og et jernpreparat for fremstilling av et farmasoytisk kombinasjonspreparat for behandling av hemodialysepasienter, eller for behandling av anemier

Country Status (26)

Country Link
US (2) US6333306B1 (no)
EP (1) EP0851762B1 (no)
JP (1) JP4783482B2 (no)
KR (1) KR100350761B1 (no)
CN (1) CN1133463C (no)
AT (1) ATE216256T1 (no)
AU (1) AU724623B2 (no)
BR (1) BR9609971A (no)
CA (1) CA2231192C (no)
CZ (1) CZ291427B6 (no)
DE (3) DE19535571A1 (no)
DK (1) DK0851762T3 (no)
EE (1) EE03856B1 (no)
ES (1) ES2174107T3 (no)
HU (1) HU225363B1 (no)
IL (2) IL123640A0 (no)
MX (1) MX9801922A (no)
NO (1) NO329908B1 (no)
NZ (1) NZ319132A (no)
PL (1) PL186776B1 (no)
PT (1) PT851762E (no)
SK (1) SK285796B6 (no)
TR (1) TR199800472T1 (no)
UA (1) UA57713C2 (no)
WO (1) WO1997009996A1 (no)
ZA (1) ZA967732B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT977582E (pt) * 1997-03-18 2002-12-31 Roche Diagnostics Gmbh Preparacoes farmaceuticas associadas contendo eritropoietina e preparacoes de ferro
EP0885613A1 (de) * 1997-06-21 1998-12-23 Roche Diagnostics GmbH Verwendung von modifizierten Hämoglobinen zur Behandlung von Anämien und Kombinationspräparate umfassend Erythropoietin und modifiziertes Hämoglobin
DE19734293A1 (de) * 1997-08-08 1999-02-11 Boehringer Mannheim Gmbh Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen
US7304150B1 (en) 1998-10-23 2007-12-04 Amgen Inc. Methods and compositions for the prevention and treatment of anemia
PT1813624E (pt) * 1998-10-23 2010-10-27 Amgen Inc Métodos e composições para a prevenção e tratamento da anemia
CA2431964C (en) 2000-12-20 2013-09-10 F. Hoffmann-La Roche Ag Conjugates of erythropoietin (pep) with polyethylene glycol (peg)
EP1909106B1 (en) * 2001-09-14 2013-01-02 F. Hoffmann-La Roche AG Differential diagnosis of disorders of iron metabolism by means of four parameters and recommendations for the treatment of these disorders of iron metabolism
US6930086B2 (en) 2001-09-25 2005-08-16 Hoffmann-La Roche Inc. Diglycosylated erythropoietin
US7300915B2 (en) * 2002-06-05 2007-11-27 The Regents Of The University Of California Use of erythropoietin and erythropoietin mimetics for the treatment of neuropathic pain
US7459435B2 (en) * 2002-08-29 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
US7459436B2 (en) 2002-11-22 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
US7964568B2 (en) * 2003-05-30 2011-06-21 Chromaceutical Advanced Technologies, Inc. Synthesis of high molecular weight iron-saccharidic complexes
RU2273485C2 (ru) * 2004-05-19 2006-04-10 Виктор Николаевич Алейников Железосодержащий препарат "феррал"
US7772182B2 (en) * 2004-08-05 2010-08-10 Alza Corporation Stable suspension formulations of erythropoietin receptor agonists
US7586589B2 (en) * 2005-09-24 2009-09-08 Beckman Coulter, Inc. Methods of determination of responsiveness to erythropoietin treatment
PL2054074T3 (pl) 2006-08-04 2015-03-31 Prolong Pharmaceuticals Llc Zmodyfikowana erytropoetyna
CL2008002054A1 (es) * 2007-07-17 2009-05-29 Hoffmann La Roche Metodo para la regeneracion de una columna de cromatografia de intercambio cationico despues de la elusion de eritropoyetina monopeguilada y metodo para obtener una eritropoyetina monopeguilada, incorporando el metodo de regeneracion de la columna de intercambio cationico.
CL2008002053A1 (es) * 2007-07-17 2009-05-22 Hoffmann La Roche Metodo para la purificacion de una eritropoyetina monopeguilada (epompeg) que consiste en proporcionar una solucion que contiene eritropoyetina mono, poli y no peguilada y hacerla pasar por dos pasos de cromatografia de intercambio cationico y metodo para producir epo mpeg que incluye metodo de purificacion.
SG10201910773VA (en) 2013-06-13 2020-01-30 Akebia Therapeutics Inc Compositions and methods for treating anemia
PT3380487T (pt) 2015-11-23 2020-10-29 Bristol Myers Squibb Co Sistemas de aditivos para utilização na peguilação de proteínas

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6039681B2 (ja) * 1976-01-01 1985-09-07 日本臓器製薬株式会社 デキストリン・クエン酸・第二鉄多核複合体及び該複合体を含有する非経口用鉄剤
IL77081A (en) 1984-12-04 1999-10-28 Genetics Inst Dna sequence encoding human erythropoietin process for the preparation thereof and a pharmaceutical composition of human erythropoietin
US4745099A (en) * 1985-02-06 1988-05-17 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition for the treatment of the anemia of malignant tumors
JPS6231A (ja) * 1985-02-06 1987-01-06 Chugai Pharmaceut Co Ltd 腎性貧血治療剤
NO881507D0 (no) * 1987-04-10 1988-04-07 Ortho Pharma Corp Fremgangsmaate for forhoeyning av hematokritnivaaet til et normalt pattedyr.

Also Published As

Publication number Publication date
EE9800066A (et) 1998-08-17
CZ72698A3 (cs) 1998-07-15
EP0851762A1 (de) 1998-07-08
SK285796B6 (sk) 2007-08-02
PL186776B1 (pl) 2004-02-27
ATE216256T1 (de) 2002-05-15
ZA967732B (en) 1998-03-13
DE19535571A1 (de) 1997-03-20
HUP9900357A3 (en) 2001-04-28
EE03856B1 (et) 2002-10-15
CA2231192C (en) 2003-02-25
PL325640A1 (en) 1998-08-03
MX9801922A (es) 1998-05-31
HU225363B1 (en) 2006-10-28
NO329908B1 (no) 2011-01-24
ES2174107T3 (es) 2002-11-01
DK0851762T3 (da) 2002-08-12
SK32798A3 (en) 1999-03-12
CZ291427B6 (cs) 2003-03-12
AU7128296A (en) 1997-04-01
BR9609971A (pt) 1999-09-14
WO1997009996A1 (de) 1997-03-20
IL123640A (en) 2006-06-11
JPH11512414A (ja) 1999-10-26
US6333306B1 (en) 2001-12-25
EP0851762B1 (de) 2002-04-17
KR100350761B1 (ko) 2003-03-03
JP4783482B2 (ja) 2011-09-28
DE59609099D1 (de) 2002-05-23
IL123640A0 (en) 1998-10-30
HUP9900357A2 (hu) 1999-05-28
UA57713C2 (uk) 2003-07-15
DE19680768D2 (de) 1998-11-05
US20020049161A1 (en) 2002-04-25
CN1202113A (zh) 1998-12-16
CN1133463C (zh) 2004-01-07
KR19990044610A (ko) 1999-06-25
NZ319132A (en) 1999-09-29
CA2231192A1 (en) 1997-03-20
TR199800472T1 (xx) 1998-06-22
AU724623B2 (en) 2000-09-28
NO981136D0 (no) 1998-03-13
PT851762E (pt) 2002-08-30

Similar Documents

Publication Publication Date Title
NO981136L (no) Farmasöytiske kombinasjonspreparater inneholdende erytropoietin og jernpreparater
IL112664A (en) 4-amino derivatives of mycophenolic acid their preparation and pharmaceutical compositions containing them
NO20015584L (no) Langtidsvarende insulintropiske peptider og konjugater samt anvendelse for fremstilling av medikamenter for behandling
IL112667A (en) 6-substituted derivatives of mycophenolic acid their preparation and pharmaceutical compositions containing them
ATE311908T1 (de) Orale verabreichung von chemisch modifizierten proteinen
ATE263571T1 (de) Verwendung von erythropoietin und eisenpräparaten zur herstellung von pharmazeutischen kombinationspräparaten zur behandlung von rheumatischen erkrankungen
HU911756D0 (en) Process for the production of medical preparations containing magnesium-pyridoxal-5'-phosphate-glutaminate, for the preventing of arterial diseases
DK0996462T3 (da) Farmaceutiske kombinationspræparater indeholdende erythropoietin og modificerede hæmoglobiner
ATE222118T1 (de) Pharmazeutische kombinationspräparate enthaltend erythropoietin und eisenpräparate
HU902004D0 (en) New trombolitic preparations
CA2060560A1 (en) Method for insuring adequate intracellular glutathione in tissue
TR200000455T2 (tr) Alzheimer hastalığının tedavisinde fankinonun kullanılması.
TW374085B (en) Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use
IL112668A (en) 4-Amino 6-substituted mycophenolic acid and derivatives thereof their preparation and pharmaceutical compositions containing them
TWI263502B (en) Pharmaceutical preparation for treating ischemic disease of heart or limbs
TR199902305T2 (xx) Eritropoitein ve demir preperasyonları içeren farmasötik birleşimli preperasyonlar.
UA19647A (uk) Спосіб лікуваhhя остеомієліту щелепи
GEU1999444Y (en) Medicinal Means “Barambo”
UA10219A (uk) Спосіб лікування туберкульозу легень

Legal Events

Date Code Title Description
MK1K Patent expired